MEDICAL DEVICE TREAT

Brand	Owner (click to sort)	Address	Description
BURST	NEVRO CORP.	1800 Bridge Parkway Redwood City CA 94065	medical device to treat and manage pain;
BURST STIMULATION	NEVRO CORP.	1800 Bridge Parkway Redwood City CA 94065	medical device to treat and manage pain;
GOT DATA?	NEVRO CORP.	1800 Bridge Parkway Redwood City CA 94065	medical device to treat and manage pain;
HF-SCS	NEVRO CORP.	1800 Bridge Parkway Redwood City CA 94065	medical device to treat and manage pain;
HIGH FREQUENCY	NEVRO CORP.	1800 Bridge Parkway Redwood City CA 94065	medical device to treat and manage pain;

HIGH FREQUENCY BURST	NEVRO CORP.	1800 Bridge Parkway Redwood City CA 94065	medical device to treat and manage pain;
HIGH FREQUENCY SCS	NEVRO CORP.	1800 Bridge Parkway Redwood City CA 94065	medical device to treat and manage pain;
PARESTHESIA-FREE BURST	NEVRO CORP.	1800 Bridge Parkway Redwood City CA 94065	medical device to treat and manage pain;
PARESTHESIA-FREE HIGH FREQUENCY	NEVRO CORP.	1800 Bridge Parkway Redwood City CA 94065	medical device to treat and manage pain;
PARESTHESIA-FREE SCS	NEVRO CORP.	1800 Bridge Parkway Redwood City CA 94065	medical device to treat and manage pain;
PARESTHESIA-FREE STIMULATION	NEVRO CORP.	1800 Bridge Parkway Redwood City CA 94065	medical device to treat and manage pain;
SCIONIC	GRoK Technologies	P.O. Box 58673 Houston TX 77258	medical device to treat and regulate pain and inflammation in humans and animals;
SCIONIC	GRoK Technologies	P.O. Box 58673 Houston TX 77258	Medical device to treat and regulate pain and inflammation in humans and animals;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. In addition to reducing or substantially eliminating a biological organism's reaction to the introduction of the medical device to the organism, the medical device in combination with one or more therapeutic drugs, agents and/or compounds may be utilized to treat various vascular diseases, for example, restenosis and vulnerable plaque. In the case of vulnerable plaque, one or more drugs, agents or compounds may be utilized to treat the various aspects of vulnerable plaque and these drugs, agents and/or compounds may be released with a given release profile for the most effective treatment. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.